Vimarsana
Biggest News Aggregation in the World

Page 13 - Breakthrough Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Devices Program Today - Breaking & Trending Today

VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update - Vimarsana News

VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended...

VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update - Vimarsana News

VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended...

The FDA Releases New Draft Guidance On Considering Health Care Disparities When Reviewing Proposed Devices - Healthcare - Vimarsana News

The FDA Releases New Draft Guidance On Considering Health Care Disparities When Reviewing Proposed Devices - Healthcare

On October 21st, the U.S. Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency's 2018 guidance on its Breakthrough Devices Program...

Source: mondaq.com
AVITA Medical Announces FDA Breakthrough Device - Vimarsana News

AVITA Medical Announces FDA Breakthrough Device

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine...

FDA Roundup: October 28, 2022 - Vimarsana News

FDA Roundup: October 28, 2022

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the...